| Bioactivity | HBV-IN-39-d3 (Example 14) is a deuterated HBV-IN-39 (Example 13). HBV-IN-39 is an HBV inhibitor. HBV-IN-39-d3 has better oral bioavailability than HBV-IN-39[1]. |
| Name | HBV-IN-39-d3 |
| CAS | 2173356-23-3 |
| Formula | C23H25D3FNO6 |
| Molar Mass | 436.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yi Chen, et al. Therapeutic agents for the treatment of HBV infection. Patent CN110240596B. |
HBV-IN-39-d3
CAS: 2173356-23-3 F: C23H25D3FNO6 W: 436.49
HBV-IN-39-d3 (Example 14) is a deuterated HBV-IN-39 (Example 13). HBV-IN-39 is an HBV inhibitor. HBV-IN-39-d3 has better
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.